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Facioscapulohumeral muscular dystrophy (FSHD) has recently been 
shown to be associated with deletions that are detectable using probe 
p13E-11 (D4F104S1). Although these deletions reside within large, 
highly polymorphic restriction fragments (20-300 kb), the “ mutant” 
fragment is usually shorter than 28 kb and can routinely be detected 
using conventional agarose gel electrophoresis. Yet, the complete vi­
sualization of the alleles requires pulsed-field gel electrophoresis 
(PFGE). Family studies showed that p13E-11 detects two nonallelic loci 
in this size range, only one of which originates from chromosome 4q35. 
We have assigned the other p13E-11 locus to chromosome lOqter by 
linkage analysis in CEPH pedigrees. Knowing the location of both loci 
improves the diagnostic reliability, as the exact origin of "small” EcoRI 
fragments can be determined by haplotyping. Since FSHD shows ge­
netic heterogeneity, this 10qter locus became an interesting candidate 
to be the second FSHD locus. However, analysis of a large chromosome 
4-unlinked FSHD family did not provide evidence for linkage on chro­
mosome 10qter> © 1995 John Wiley & Sons, Inc.
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f a c io s c a p u lo h u m e r a l  m uscular d y s tro p h y  
(FSHD) is one of the three major forms of muscu­
lar dystrophy, along with the Duchenne/Becker 
and limb girdle forms. The onset of FSHD is char­
acterized by weakness of facial, shoulder girdle, 
and upper-arm  muscles. Where there is progres­
sion of the disease, the weakness and atrophy
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spreads to the foot extensor, upper arm, and pel- 
vic-girdle muscles."1,5 Although FSHD shows a 
characteristic autosom al-dom inant inheritance 
pattern, isolated patients are discovered quite fre­
quently, suggesting a high new mutation fre­
quency of the disease.
The gene defect involved in the majority of 
families is localized to chromosome 4q35, distal to 
the linkage group cen . . . D4F171—FI 1— D4S163- 
D4S139.7 More recently, specific deletion frag­
ments associated with the etiology of FSHD have 
been cloned and characterized.9 These deletions 
occur within polymorphic EcoRI or H in d lll  frag­
ments and can be detected by conventional Southern 
analysis using probe p !3 E -ll  (D4F104S1).6,8,10,14 
In general, the deletion fragments are smaller than 
28 kb. However, to reveal the complete polymor­
phism detected by p l3E -l 1, separation by pulsed- 
field gel electrophoresis (PFGE) is required since 
fragments can range in size from less than 20 kb to 
more than 300 kb. Interestingly, PFGE reveals the 
presence of two nonallelic loci.13 Using haplotype 
analysis, one locus could be assigned to chromo­
some 4q35. Despite the fact that FSHD patients
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exhibit p l3 E - l l  detectable fragments that are 
smaller than 28 kb, sometimes healthy individuals 
also display “small” p l3 E -l 1 fragments that can be 
visualized quite easily on conventional agarose 
gels. These “small” fragments most likely originate 
from the non~4q35 locus since polymorphic frag­
ments originating from 4q35 seem to be at least 50
kb in length in normal individuals.13
Although a “small” p l3 E - l l  detectable frag­
ment by itself is not diagnostic for FSHD, it be­
comes so when its origin is defined to be chromo­
some 4q35. In  this study, we localize the second 
p l 3 E - l l  po lym orph ic  locus to chrom osom e 
lOqter, which will facilitate the differentiation be­
tween the two p l3E -l 1 loci and thereby improving 
the diagnostic power.
Since FSHD shows genetic heterogeneity,3 it 
was attractive to consider this second p l3 E - l l  lo­
cus to be the second FSHD locus. We investigated 
the potential linkage between the second p l3 E - ll  
locus and FSHD in a large Danish FSHD family 
that was excluded for linkage with 4q35 markers.
M ATERIALS AND M ETHODS
Subjects. This study encompasses a large multi- 
generational Danish FSHD family consisting of 11 
affected and 12 unaffected individuals (see Fig.
1 A). This family shows an autosomal-dominant in­
heritance pattern. Most patients were subjected to 
repeated physical investigations by independent 
neurologists. Three cases had a muscle biopsy and 
electromyography to establish the diagnosis of
FSHD.
Analysis of p13E-11. The Centre d ’Etude Poly- 
morfisme Humaine (CEPH)2 provided, as a part of 
the EUROGEM project, ready-to-hybridize South­
ern blots ofEcoRI-digested DNA samples from the 
CEPH pedigrees members. They also provided mi­
crotiter plates with DNA samples of members of 
the CEPH pedigrees. Hybridization with a32P- 
dCTP-labeled probe p 13E-11 was performed 
overnight at 65°C according to Church and 
Gilbert.1 Filters were washed to a stringency of 1 X 
SSC/0.1% SDS, followed by autoradiography for 
1—3 days using an intensifying screen.
Analysis of Microsatellite Markers. Amplification 
of microsatellites is perform ed in a microtiter 
plate. The reaction volume is 15 |xl containing 10 
mmol/L Tris-HCl, pH 9.0; 50 mmol/L KC1; 0.01% 
gelatine; 1.5 mmol/L MgCl2; 0.1% Triton X-100; 
0.06 U Supertaq DNA polymerase (HT Biotech­
nology Ltd.); 200 (xmol/L each of dATP, dGTP, 
and dTTP; 2.5 fxmol/L dCTP; 0.75 \j.Ci a 32P- 
dCTP (at 3000 Ci/mmol); 30 ng of each oligonu-
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FIGURE 1. (A) Danish FSHD pedigree, number below individuals indicate DNA sample numbers. (B) Southern blot of £coRI 
digested genomic DNA, hybridized with probe p13E-11. Sample numbers correspond with numbers in the pedigree (A).
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cleotide primer; and 30 or 200 ng of genomic 
DNA template. Samples are processed in a ther- 
mocycler (MJ Research) through 27 cycles (30 ng 
DNA), or 20 cycles (200 ng DNA) consisting of 1 
min at 94°C, 2 min at 55°C, and 1 min at 72°C.
Some of the microsatellite loci are amplified simul­
taneously.
After PCR, 1 volume of formamide sample 
buffer (95% formamide, 20 mmol/L EDTA, 0.05% 
bromophenol blue, 0.05% xylene cyanol) is added 
to the samples. The samples are denaturated (5 
min at 94°C) and loaded on a DNA sequencing gel 
(6% acrylamide/bisacrylamide 19:1, 7 mol/L urea,
0.35% APS, 0.07% TEMED, in 1 x TBE). Electro­
phoresis is performed for 3 h at 40 mA and 65 W. 
Prior to loading and electrophoresis the upper 
buffer compartment is filled with 0.5 X TBE, the 
lower buffer compartment with 5/6 X TBE/0.5 
mol/L NaAc and the gel is prerun for 0.5 h. Dideoxy 
sequencing reactions of phage M13mpl8 are loaded 
on the gel as size standards. After electrophoresis the 
gel is fixed for 20 min in 5% methanol/5 % acetic 
acid. The gel is dried and exposed to an X-ray film at 
room temperature for 2 h or overnight.
Linkage Analysis. Linkage analysis in the CEPH 
pedigree set was carried out to establish the posi­
tion of the nonchromosome 4 p 13E-11 locus on 
the genetic linkage map. Since not all EcoRl frag­
ments detected by p l3 E -ll  can be identified using 
conventional agarose gels, the polymorphism was 
scored as a two- or three-allele system. Individuals 
with only fragments larger than 28 kb were scored 
as homozygous (1,1) and individuals with a frag­
ment smaller than 28 kb were scored as heterozy­
gous (1,2).
Two-point linkage analysis in the Danish FSHD 
family was carried out using the MLINK program 
of the LINKAGE package, Version 5.1, assuming 
equal recombination fractions in males and fe­
males, a gene frequency of 0.00005, and a pene­
trance of 95%.12
RESULTS
Assignment of the Second p13E-11 Locus to lOqter.
From a total of 20 CEPH pedigrees both pairs of 
grandparents were genotyped using p l3 E - l l .  
Among these 80 individuals (160 chromosomes), 8 
showed a fragment which was smaller than 28 kb, 
implying a 10% chance of detecting a “small” 
p l3 E - l l  fragment. Of seven CEPH pedigrees an­
alyzed with p l3 E -ll ,  four (1346, 1375, 1416, and 
1423) showed segregation of the “small” band. In 
CEPH pedigree 1416, two different and easily dis­
tinguishable “small” p l3 E - l l  fragments were
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FIGURE 2. CEPH pedigree 1416 with Southern blot results for 
probe p13E-11. Alleles longer than 28 kb are indicated with a 
t, two alleles shorter than 28 kb are indicated by 2 and 3, 
respectively.
found to segregate independently (Fig. 2), yielding 
a total of 18 possibly informative meioses. The 
other three families showed one “small” p l3 E -ll  
fragment of which the segregation could be fol­
lowed through the pedigrees, yielding a total of 36 
possibly informative meioses. Using the data from 
the Version 6.0 CEPH database, significant linkage 
was detected between these "small” p 13E-11 frag­
ments and different chromosome lOq markers 
in the four families (data shown for pedigree 
1416; Figs. 2 and 3). Several additional markers 
(e.g., AFM 198zb4,D10S212 and  AFM304whl, 
D10S590) mapping to chromosome lOq were 
tested in the four CEPH pedigrees. The results of 
the two-point linkage analysis are shown in Table
1. The most closely linked m arker, D10S590, 
showed a recombination frequency of 0.05 with a 
lod score of 4.0. Multipoint linkage analysis sug­
gests the following locus order to be the most likely
one: D 10S217-(13  cM)-{D 10S212-(1 cM )-
D10S180—(1 cM)-D10S590H6 cM )-pl3E -ll
te l The position of p l3 E - l l  with respect to this 
linkage group is distal, based on one recombina­
tion event between D10S590 and p 13E-11 in 
CEPH family 1416 (see Fig. 3).
Two-point linkage analysis between the FSHD 
locus and a marker from the FSHD gene region on 
chromosome 4q35 (pH30; locus D4S139) was per­
formed in the large Danish FSHD family. This 
family shows five (out of 19 informative) meioses 
where FSHD apparently recombines with D4S139 
(see Fig. 4A). Exclusion of linkage for this FSHD 
locus to chromosome 4q35-qter is evident with a 
lod score of -2 .2  at 10 cM.
I I I
Table 1. Lod scores for p13E-11 vs. chromosome 10 markers
in CEPH pedigrees.
cM Lod
P13E-11 vs. D10S590 5.0 4.0
P13E-11 vs, D10S180 5.6 3.74
P13E-11 vs. D10S212 6.6 5.84
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FIGURE 3. CEPH pedigree 1416 showing cosegregation of p13E-11 alleles with alleles of two chromosome 10 markers*
Analysis of this family with p I3E -Il (Fig. IB) 
l'evealed the presence of a detectable fragment of 
30 kb on a conventional agarose gel. Linkage anal­
ysis between this “30-kb” p l3 E - l l  fragment and 
pH30 yielded no recombinants and a lod score 
3.24 confirming that this 30-kb p l3 E - l l  allele is 
located on chromosome 4q35 (Fig* 4A).
To test whether chromosome lOq contains a 
second FSHD locus, multipoint linkage studies 
were performed between FSHD and the lOq mark­
ers D10S212 and D10S590, and linkage was ex­
cluded with a lod score of —2 at 15 cM (in 18 
informative meioses 6 recombinants were detected; 
see Fig. 4B).
D ISCUSSIO N
The molecular diagnosis of FSHD can be carried 
out successfully using probe p l3 E - l l .  However, 
due to the complexity of the banding pattern gen­
erated by p !3E -l 1, a reliable diagnosis requires the 
detection of a de novo DNA rearrangement, or 
tight linkage of FSHD to a “small” (<28 kb) pl3E-
11 fragment. In 10% of 80 random individuals 
studied, “small” p !3 E - l l  fragments can be found, 
which are not associated with FSHD. The occur­
rence of these nonchromosome 4 fragments in 
FSHD families can ham per the diagnosis. The lat­
ter fragments were mapped to chromosome lOq. 
Hence, adjacent markers from chromosomes 4 
and 10 can be used to decide whether a given frag­
ment originates from the FSHD locus on chromo­
some 4q, or from the other locus on chromosome 
lOq.
The mapping of a locus to chromosome lOq
which is highly homologous to the FSHD locus on 
chromosome 4q,13 is in line with previous observa­
tions, that the p l3E -l 1—derived cosmid clone 
shows cross-hybridization with chromosomes lq 12 
and lOq, and the p-arm of acrocentric chromo­
somes using fluorescent in situ hybridization.12 In 
addition, a CA repeat isolated from a p l3 E -ll + 
chromosome 4 cosmid clone (D4F106S1)14 was 
found to map to lOqter using a somatic cell hybrid 
panel (Wright TJ, Hewitt J, personal communica­
tion). On the basis of this similarity, it is possible 
that these regions on both chromosome 4 and 10 
contain similar genes as well, including the puta­
tive FSHD gene. Therefore, FSHD families u n ­
linked to the 4q locus might show linkage to the 
chromosome 10 locus. One such family was tested 
in this study, but appeared to be unlinked. How­
ever, this does not exclude the possibility that other 
FSHD families unlinked to chromosome 4 can 
show linkage to the markers on chromosome 10.
The striking homology between the 4q and lOq 
telomeres may offer an explanation for the disrup­
tion of the FSHD gene, because cryptic transloca­
tions between these two chromosomes might oc­
cur. At present this hypothesis cannot be tested 
due to the lack of probes distal to D4F104S1. How­
ever, the fact that sporadic patients show only one 
rearranged fragment and not two reciprocal prod­
ucts as would be expected from a ti'anslocation, 
strongly favors the deletion-type of mutation de­
scribed by van Deutekom et al.9
The observation that a 30-kb p 13E-11 frag­
ment in the Danish FSHD family is linked to chro­
mosome 4 but not to the FSHD is unexpected, as 
the so called normal p l3 E -ll  alleles on chromo-
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FIGURE 4. (A) Danish FSHD pedigree showing cosegregation of a 30-kb alleie of p13E-11 with the chromosome 4q35 marker 
D4S139. The FSHD in this pedigree does not segregate with chromosome 4q35. Individuals 29, 39, 1, 21, and 17 all show a 
crossover. (B) Danish FSHD pedigree demonstrating nonlinkage of FSHD with the chromosome 10q markers D10S590 and 
D10S212. Individuals 22, 11, 16, 17, 13, and 32 all show a recombination.
some 4 are believed to be over 50 kb.13 Therefore, 
one has to be careful in the interpretation of 
Southern blot detectable p l3 E - ll  alleles (both 
smaller and larger then 28 kb) in relation to FSHD.
A clear relationship can only be proven if a de 
novo fragment arises with the sporadic occurrence 
of FSHD, or if in a family linkage to chromosome 
4 is proven. Exclusion of linkage of a “small” frag-
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ment to chromosome 10q markers might be an in­
dication of a FSHD-associated p l3 E - l l  allele on 
chromosome 4.
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